The LeForte System includes orthopedic implants used in craniomaxillofacial procedures, such as trauma and reconstruction. Bacterin plans a beta-launch of the LeForte System in the United States and Canada next month with the full product release to occur during the second quarter of 2012.
As a result of the agreement, the company has promoted Nick Navarro to executive vice president of medical devices. Mr. Navarro has previous experience with Johnson & Johnson.
Related Articles on Orthopedic Devices:
Global Orthopedic Implant Market to Reach $46.5B by 2017
InVivo Therapeutics Reports $3M Net Income in 3Q
Alphatec Spine Names Frances Harrison to Vice President Position
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
